1. 109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials. (September 2022) Authors: Nabid, Abdenour; Carrier, Nathalie; Vigneault, Eric; Vavassis, Peter; Brassard, Marc-André; Bahoric, Boris; Archambault, Robert; Vincent, François; Bettahar, Redouane; Wilke, Derek; Van Nguyen, Thu; Martin, André-Guy; Bahary, Jean-Paul; Duclos, Marie; Vass, Sylvie; Souhami, Luis Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 11 Prostate Bed Treatment Intensification with Long Term Androgen Deprivation and Pelvic Nodal Radiotherapy is Effective and Well Tolerated: Results from the McGill 0913 Phase II Clinical Trial. (October 2019) Authors: Kucharczyk, Michael; Tsui, James; Bahoric, Boris; Souhami, Luis; Niazi, Tamim Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 155: Calcification and Image Guided Radiotherapy for Localized High-Risk Prostate Cancer. (September 2022) Authors: Faria, Sergio; Cuclos, Marie; Cury, Fabio; Patrocinio, Horacio; Souhami, Luis Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 171 High-Dose-Rate Brachytherapy as Monotherapy for the Treatment of Intermediate Risk Prostate Cancer: Toxicity Results. (October 2019) Authors: Katib, Yousef; Sani, Cyrus; Sioufi, Richard; Faria, Sergio; Aprikian, Armen; Cury, Fabio; Souhami, Luis; Duclos, Marie Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 24 Subsequent Androgen Deprivation Therapy After Initial Treatment in Intermediate Risk Prostate Cancer: Prospective Data from a Phase III Trial. (October 2019) Authors: Nabid, Abdenour; Carrier, Nathalie; Vigneault, Eric; Van Nguyen, Thu; Vavassis, Peter; Brassard, Marc-André; Bahoric, Boris; Archambault, Robert; Vincent, François; Bettahar, Redouane; Wilke, Derek; Souhami, Luis; Nabid, Abdenour Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 30 Retrospective Evaluation of the Effects of Interobserver Contouring Practices in Clinical Practice. (October 2019) Authors: Patrick, Haley; Souhami, Luis; Kildea, John Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 4: A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter (A01-M121-11A, MCG1132). (September 2022) Authors: Faye, Mame Daro; Sabri, Siham; Robles, Paula De; Easaw, Jacob; Agnihotram, Raman; Torres-Vasquez, Alexander; Panet-Raymond, Valerie; Shenouda, George; Souhami, Luis; Abdulkarim, Bassam Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 53: Acute and Late Toxicity in High-Risk Prostate Cancer Patients Treated with Androgen Suppression and Hypofractionated Radiotherapy (Hyport) to the Prostate and Pelvic Nodes. (September 2016) Authors: Faria, Sergio; Petrucelli, Mariana; Cury, Fabio; Duclos, Marie; Souhami, Luis Journal: Radiotherapy and oncology Issue: Volume 120(2016)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 56: Phase 2 Trial of Neoadjuvant Metformin and Temozolomide Followed by Hypofractionated Accelerated Radiotherapy with Concomitant and Adjuvant Metformin and Temozolomide in Patients with Newly Diagnosed Glioblastom. (September 2022) Authors: Shenouda, George; Petrecca, Kevin; Abdulkarim, Bassam; Owen, Scott; Panet-Raymond, Valerie; Diaz, Roberto; Guiot, Marie-Christine; Hall, Jeffery; Charbonneau, Melissa; Carvalho, Tatiana; Souhami, Luis Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 62: Acute Toxicity in High-Risk Prostate Cancer Patients Treated with Extreme Hypofractionation (HRPC-SBRT). (September 2022) Authors: Faria, Sergio; Duclos, Marie; Aldohan, Mohammed; Cury, Fabio; Patrocinio, Horacio; Souhami, Luis Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗